Description
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Product Unit Size | Cost | Quantity | Stock |
|---|
HIV protease substrate ARVLAEA is a peptide binding epitope of the capsid CA-p2 cleavage site.
| Purity | ≥98% |
|---|---|
| Formula | C33H59N11O10 |
| Formula Wt. | 769.90 |
| Solubility | Soluble in water (2 mg/mL), acetonitrile. |
| Store Temp | -20°C |
|---|---|
| Ship Temp | Ambient |
| Info Sheet |
|---|
Prabu-Jeyabalan M, Nalivaika E, Schiffer CA. How does a symmetric dimer recognize an asymmetric substrate? A substrate complex of HIV-1 protease. J Mol Biol. 2000 Sep 1;301(5):1207-20. PMID: 10966816.
Peptidyl transferase inhibitor, protein transla...
Analog of rapamycin.
Thiol derivative, antioxidant.
DOPA decarboxylase inhibitor, indirect α2-adre...
Diterpene found in brewed, unfiltered coffee; F...
Triterpenoid
Allylamine; squalene oxidase and KSR1 inhibitor...
Nucleotide analog; RT inhibitor.
Taxane found in species of Taxus; potential mic...
Alkaloid compound originally found in Corydalis...
Pyrrolopyrimidine; Akt inhibitor.
VEGFR, PDGFR, c-Kit inhibitor.
STING agonist
PI3K inhibitor, microtubule polymerization inhi...
2’-Benzoylcarbonyl D-seco-Taxol is an impurit...
NSAID; COX-1/2 inhibitor.
Proteasome inhibitor.
Statin; HMG-CoA reductase inhibitor.
Mycotoxin produced by Aspergillus and Penicillu...
Roscovitine analog; CDK inhibitor.